-
Mashup Score: 24The Uromigos • A podcast on Spotify for Podcasters - 2 day(s) ago
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is Chief of Clinical Trials, Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Centre Tom Powles is Director of Barts Cancer Centre, St Bartholomews Hospital and Professor or Genitourinary oncology, Queen Mary University of London
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 14Episode 314: APCCC 2024 Cardiovascular risks with hormone therapy in prostate cancer by The Uromigos - 10 day(s) ago
Thomas Suter and Chuck Ryan discuss identification and management of cardiovascular disease for patients starting therapy for prostate cancer.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 12
David Penson discusses highlights for the upcoming meeting. He articulates his excitement around the NMIBC data.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6Episode 15 - Is “Practice Creep” allowing Physicians and PAs/NPs to Practice Beyond the Scope of Training? by Heart of Medicine - 14 day(s) ago
The last time you went to the emergency room or to a doctor’s office, were you surprised to be seen by a Nurse Practitioner or Physician Assistants/Associate only rather than a physician or a team of people? Does it seem like there are more and more of these types of encounters in medicine, where the doctor isn’t even part of the visit? Historically, the role of a NP and PA had been developed to improve access to healthcare and offload physicians from more of the straightforward patient care tasks in medicine. However, more recently the role of these types of providers, called APPs, has evolved into becoming specialists, addressing new problems independently, managing complex patients and even performing complicated surgical procedures. The APPs can even switch specialities without having to train the way a physician would to switch and in many states, don’t need physician supervision to practice. So where does this leave us… Has this has impacted the care of patients? The trust patien
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 18
Hans Hammers discusses trial design and patient selection in the adjuvant setting.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 23Episode 300: Adjuvant PD1 Therapy in Solid Tumours by The Uromigos - 3 month(s) ago
David McDermott discusses melanoma and renal data. We never get to bladder or lung.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 23Episode 300: Adjuvant PD1 Therapy in Solid Tumours by The Uromigos - 3 month(s) ago
David McDermott discusses melanoma and renal data. We never get to bladder or lung.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 30Episode 298: ASCO GU 2024 Highlights by The Uromigos - 3 month(s) ago
Silke, Tom and Brian cover the bases.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 26Episode 298: ASCO GU 2024 Highlights by The Uromigos - 3 month(s) ago
Silke, Tom and Brian cover the bases.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 17
Pedro Barata summarises his ASCO GU discussion on this topic.
Source: spotifyanchor-web.app.linkCategories: General Medicine News, UrologyTweet
Great podcast with @Prof_Nick_James on the @TheLancet Prostate Cancer Commision examining the many aspects of the challenges for #prostatecancer for the next generation. https://t.co/mt0xAbBn0i